Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.
CONCLUSION: Omalizumab was effective for the treatment of patients with recalcitrant CRSwNP and mild asthma, even when AERD was present, by reducing NP size and improving QoL; treatment time was a key factor. SNOT-22 improvements were not explained by decreases in TPS, indicating that omalizumab may be effective in all patients, regardless of polyp size.
PMID: 33153272 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - Category: ENT & OMF Authors: Armengot-Carceller M, Gómez-Gómez MJ, García-Navalón C, Doménech-Campos E, Muñoz-Fernández N, Miguel AG, Marco-Algarra J, Palop-Cervera M, Piñero AG Tags: Am J Rhinol Allergy Source Type: research
More News: Allergy | Allergy & Immunology | Aspirin | Asthma | ENT & OMF | Lower Endoscopy | Polyps | Respiratory Medicine | Spain Health | Study | Xolair